Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

Symptom Spectrum and Risk Factors for Fever in Pediatric and Adult Patients With Omicron Infection

  • Read more about Symptom Spectrum and Risk Factors for Fever in Pediatric and Adult Patients With Omicron Infection

A Study to Investigate 14C-bemcentinib in Healthy Male Subjects

  • Read more about A Study to Investigate 14C-bemcentinib in Healthy Male Subjects

Clinical Outcomes and Inflammatory Responses in Viral vs. Bacterial Sepsis

  • Read more about Clinical Outcomes and Inflammatory Responses in Viral vs. Bacterial Sepsis

Music Mindfulness Study 2a.

  • Read more about Music Mindfulness Study 2a.

Drum Circle Synchrony Study 2c.a.

  • Read more about Drum Circle Synchrony Study 2c.a.

Evaluating Social Perception Dynamics

  • Read more about Evaluating Social Perception Dynamics

Evaluating the Impact of Social Music

  • Read more about Evaluating the Impact of Social Music

Evaluating the Community Drum Circle

  • Read more about Evaluating the Community Drum Circle

Investigation of Physical Impairments in Young Adults

  • Read more about Investigation of Physical Impairments in Young Adults

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ALG-097558 in Subjects With Hepatic Impairment and in Healthy Subjects With Normal Hepatic Function

  • Read more about A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ALG-097558 in Subjects With Hepatic Impairment and in Healthy Subjects With Normal Hepatic Function

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 50
  • Page 51
  • Page 52
  • Page 53
  • Current page 54
  • Page 55
  • Page 56
  • Page 57
  • Page 58
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA